BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26996296)

  • 1. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
    Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2.
    Li F; Jørgensen JT; Forman J; Hansen AE; Kjaer A
    J Nucl Med; 2016 Mar; 57(3):437-43. PubMed ID: 26585061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
    Oh M; Tanaka T; Kobayashi M; Furukawa T; Mori T; Kudo T; Fujieda S; Fujibayashi Y
    Nucl Med Biol; 2009 May; 36(4):419-26. PubMed ID: 19423010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
    Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
    Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission.
    McMillan DD; Maeda J; Bell JJ; Genet MD; Phoonswadi G; Mann KA; Kraft SL; Kitamura H; Fujimori A; Yoshii Y; Furukawa T; Fujibayashi Y; Kato TA
    J Radiat Res; 2015 Sep; 56(5):784-91. PubMed ID: 26251463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
    Hueting R; Kersemans V; Cornelissen B; Tredwell M; Hussien K; Christlieb M; Gee AD; Passchier J; Smart SC; Dilworth JR; Gouverneur V; Muschel RJ
    J Nucl Med; 2014 Jan; 55(1):128-34. PubMed ID: 24337603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
    Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
    J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models.
    Tanaka T; Furukawa T; Fujieda S; Kasamatsu S; Yonekura Y; Fujibayashi Y
    Nucl Med Biol; 2006 Aug; 33(6):743-50. PubMed ID: 16934693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Uptake of the ATSM-Cu(II) Complex under Hypoxic Conditions.
    Walke GR; Meron S; Shenberger Y; Gevorkyan-Airapetov L; Ruthstein S
    ChemistryOpen; 2021 Apr; 10(4):486-492. PubMed ID: 33908707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
    Dehdashti F; Grigsby PW; Mintun MA; Lewis JS; Siegel BA; Welch MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1233-8. PubMed ID: 12654432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.
    McCall KC; Humm JL; Bartlett R; Reese M; Carlin S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e393-9. PubMed ID: 22727887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.
    Ballegeer EA; Madrill NJ; Berger KL; Agnew DW; McNiel EA
    BMC Cancer; 2013 Apr; 13():218. PubMed ID: 23631652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.
    Yoshii Y; Matsumoto H; Yoshimoto M; Furukawa T; Morokoshi Y; Sogawa C; Zhang MR; Wakizaka H; Yoshii H; Fujibayashi Y; Saga T
    PLoS One; 2014; 9(1):e86996. PubMed ID: 24466309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.